Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
This study is currently recruiting participants.
Verified March 2012
by Sun Yat-sen University
Study NCT01616849 Information provided by Sun Yat-sen University
First Received on May 20, 2012. Last Updated on June 8, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stage IV Nasopharyngeal Carcinoma
Additional conditions recognized in this trial
Carcinoma
Nasopharyngeal Neoplasms
More general conditions related to this trial
Head and Neck Neoplasms
Nasopharyngeal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Stomatognathic Diseases
Additional drug interventions recognized in this trial
Cisplatin
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Sun Yat-sen University
Fujian Provincial Cancer Hospital
First People's Hospital of Foshan
The People's Hospital of Guangxi Zhuang Autonomous Region
Guangxi Medical University
Guangzhou Medical University
Hubei Provincial Cancer Hospital
Hunan Provincial Cancer Hospital
Hangzhou Cancer hospital
Union Hospital Of Huazhong University of Science & Technology
Tongji Hospital Of Huazhong University of Science & Technology
Jiangxi Provincial Cancer Hospital
Cancer Hospital of Shantou University
Wuhan University
Zhejiang Provincial Cancer Hospital
Back to top of Main Content
